PRATI, GIAN MARIA
 Distribuzione geografica
Continente #
EU - Europa 2.506
NA - Nord America 1.805
AS - Asia 1.794
SA - Sud America 154
AF - Africa 61
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 6.347
Nazione #
US - Stati Uniti d'America 1.726
GB - Regno Unito 954
CN - Cina 577
SG - Singapore 475
DE - Germania 431
IT - Italia 314
RU - Federazione Russa 177
SE - Svezia 155
VN - Vietnam 146
HK - Hong Kong 138
BD - Bangladesh 105
BR - Brasile 103
NL - Olanda 101
IN - India 99
FR - Francia 96
UA - Ucraina 91
TR - Turchia 73
IE - Irlanda 62
CA - Canada 59
KR - Corea 57
EU - Europa 44
FI - Finlandia 42
CI - Costa d'Avorio 23
ID - Indonesia 21
CO - Colombia 20
JP - Giappone 20
AU - Australia 16
DK - Danimarca 16
CL - Cile 14
BE - Belgio 13
AR - Argentina 10
PL - Polonia 10
PH - Filippine 9
PK - Pakistan 9
UG - Uganda 9
UZ - Uzbekistan 9
EG - Egitto 8
IR - Iran 8
TW - Taiwan 8
ZA - Sudafrica 8
ES - Italia 7
IL - Israele 7
IQ - Iraq 7
MX - Messico 7
CH - Svizzera 6
BG - Bulgaria 5
MY - Malesia 5
SA - Arabia Saudita 5
AT - Austria 4
CR - Costa Rica 3
EC - Ecuador 3
EE - Estonia 3
JO - Giordania 3
KE - Kenya 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
IS - Islanda 2
JM - Giamaica 2
LV - Lettonia 2
MA - Marocco 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SM - San Marino 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BS - Bahamas 1
CG - Congo 1
DO - Repubblica Dominicana 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HU - Ungheria 1
JE - Jersey 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MQ - Martinica 1
NG - Nigeria 1
RE - Reunion 1
TM - Turkmenistan 1
WS - Samoa 1
Totale 6.385
Città #
Southend 881
Singapore 244
Ashburn 185
Chandler 168
Beijing 137
Hong Kong 117
Frankfurt am Main 85
Seattle 83
Milan 77
San Jose 75
Jacksonville 73
Princeton 68
Dearborn 60
Dublin 60
Santa Clara 54
Mountain View 51
Ann Arbor 47
Ho Chi Minh City 46
Los Angeles 46
Dallas 44
Hanoi 43
Wilmington 43
Redmond 41
Toronto 37
New York 34
Council Bluffs 32
Bengaluru 31
Serra 31
Boardman 30
Des Moines 30
Nanjing 28
Lauterbourg 25
Moscow 25
Woodbridge 25
Andover 24
Sakarya 24
Shanghai 24
Abidjan 23
Buffalo 22
Columbus 21
Guangzhou 21
Bogotá 19
Saint Petersburg 19
Jinan 17
The Dalles 17
Nanchang 16
Munich 15
Cangzhou 14
Fairfield 14
Somerville 14
Houston 13
Phoenix 13
Shenyang 13
Tianjin 13
Piscataway 12
Brussels 11
Da Nang 11
Hangzhou 11
Helsinki 11
San Diego 11
Tokyo 11
Jakarta 10
Jiaxing 10
Turin 10
Berlin 9
Kampala 9
Seoul 9
London 8
Zhengzhou 8
Cambridge 7
Changsha 7
Grafing 7
Hebei 7
Mumbai 7
San Antonio 7
Sydney 7
Chicago 6
Eitensheim 6
Fuzhou 6
Haiphong 6
Hefei 6
Ottawa 6
Redwood City 6
Rome 6
Stockholm 6
São Paulo 6
Taipei 6
Belo Horizonte 5
Bitonto 5
Bologna 5
Istanbul 5
Johannesburg 5
Kent 5
Nuremberg 5
Orem 5
Scranton 5
Shenzhen 5
Warsaw 5
Washington 5
Wuhan 5
Totale 3.743
Nome #
Prevalence of psychiatric disorders during PEG – Interferon and Ribavirin therapy in patients with chronic hepatitis HCV-correlated 397
The dica endoscopic classification for diverticular disease of the colon shows a significant interobserver agreement among community endoscopists: An international study 277
L'IMPATTO DEL POLIMORFISMO GENETICO IL 28B SUL TRATTAMENTO ANTIVIRALE CON INTERFERONE PEGHILATO E RIBAVIRINA IN PAZIENTI CON EPATITE CRONICA C GENOTIPO 4 276
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegykated interferon-α2A in chronic hepatitis C : an in vitro and in vivo study 270
The natural history of compensated cirrhosis due to hepatitis C virus : A 17-year cohort study of 214 patients 266
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C 249
Serum expression of lectin reactive alphafetoprotein, des-gamma-carboxy prothrombin, Golgi protein-73 antigen and antibody, for the diagnosis of hepatocellular carcinoma 246
The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy 240
Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatiti sC virus infected patients with cirrhosis : a single center study of 471 naive patients 231
Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients 222
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 222
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-alpha 2a in chronic hepatitis C : an in vitro and in vivo study 221
Successful treatment of hepatocellular carcinoma (HCC) with transchateter arterial embolization (TAE) with microspheres (embosphere) 219
Predictors of psychopathological outcome during peg-interferon and ribavirin therapy in patients with chronic HCV-correlated hepatitis 219
Genotype dependent pattern of Peginterferon alfa-2B/Ribavirin treatment failure in hepatitis C virus infected patients with cirrhosis : a single centre study of 471 naïve patients 215
The influence of liver fibrosis on the outcome of pegylated interferon and ribavirin anti-hac therapy : a sub-analysis of the mist study 207
The diagnostic accuracy of fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with an SVR 207
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients 205
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotype 204
Randomized Study of Peginterferon-alpha2a Plus Ribavirin vs Peginterferon-alpha2b Plus Ribavirin in Chronic Hepatitis C 199
Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis 198
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 193
Successful treatment of hepatocellular carcinoma (hcc) with transchateter arterial embolization (tae) with microspheres (embosphere) 182
Interferoni pegilati nel trattamento dei pazienti con epatite cronica HCV : esperienze a confronti 180
Single-incision laparoscopic surgery (SILS) for the treatment of ileocolonic Crohn’s disease: a propensity score–matched analysis 175
Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C 167
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study 162
Surgical treatment of colonic Crohn’s disease: a national snapshot study 154
Prospective evaluation of staging systems for hepatocellular carcinoma detected during surveillance of cirrhotic patients 150
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study 146
The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3 : Should we utilize more? 142
Totale 6.641
Categoria #
all - tutte 18.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 0 0 46
2021/2022399 36 17 7 13 16 27 37 32 54 46 36 78
2022/2023537 60 78 56 56 45 114 9 15 65 7 28 4
2023/2024359 7 29 14 24 115 36 11 20 22 13 29 39
2024/2025845 39 84 7 111 82 29 22 58 48 95 79 191
2025/20261.675 217 93 158 103 156 99 224 85 117 141 187 95
Totale 6.641